Abbott's Next-Generation Amulet 360™ Device Receives CE Mark To Treat People With Atrial Fibrillation At Risk Of Stroke
ABT•CE mark approval for Amulet 360
Abbott Laboratories said its next-generation Amulet 360™ device received a CE mark to treat people with atrial fibrillation at risk of stroke.
European rollout and early cases
Abbott said it plans to expand Amulet 360 use across Europe in the coming weeks.
The company said the first European cases using Amulet 360 have been completed in Germany and Denmark.
